Moody's gives Pfizer loan Aa1

Moody's Investors Service said it assigned a rating of Aa1 to the new senior unsecured credit facilities of Pfizer Inc.

At the same time, Moody's said it affirmed Pfizer's existing Aa1 long-term and Prime-1 short-term ratings.

Moody's said it last rating action on Pfizer was a revision of the outlook to negative from stable on Oct. 19.

The agency noted that the new senior unsecured credit facility is expected to be used as a backstop facility for Pfizer's $12 billion commercial paper program. Pfizer has recently begun to increase the size of its commercial paper borrowings, which totaled $4.4.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.